About

A small suite of tools that show their sources

AEaH is the home of two products built by Consult Sciences Ltd: PharmaTerminal, which monitors pharma R&D as it moves, and Nebula, which maps the publication evidence behind a technology.

Why this hub exists

Two separate products on two subdomains were functioning but disconnected: no shared front door, no explanation of how they relate, and no single place stating where the data comes from. This site is that missing piece — not a third product.

One entry point

A visitor can see both tools, what each does and what each costs, without having to know a subdomain in advance.

An honest data statement

The sourcing rules and the limits of every upstream dataset are written down once, publicly, on methodology, instead of being scattered across two products.

A route to the practice

The tools are the productised form of a consulting practice. Teams that need the work done rather than a login have a path — see services.

Why two products and not one

Because they carry different data with different lifetimes and different costs, and bolting them together would have made both worse.

Monitoring is fast and perishable

Quotes, filings, scheduled action dates and news decay in hours. PharmaTerminal is built for that cadence: refresh often, alert on change, keep the panels you care about. Running costs scale with usage, which is why it has paid tiers.

Evidence is slow and durable

A publication record is stable for years. Nebula is built for a different cadence: a corpus is curated and mapped, then explored. It costs little to serve, so it is free — and it can afford to be explicit about how thin some of the underlying data is.

The company

Consult Sciences Ltd

Consult Sciences Ltd is a clinical development and life-sciences consultancy based in the United Kingdom. It builds and operates PharmaTerminal and Nebula, and uses them in its own diligence work — which is the reason they exist at all.

Get in touch

For commercial enquiries, coverage requests, data corrections or anything about access: enquiries are handled through the consultancy site above. Product-specific support runs through each product — PharmaTerminal has a support and contact route in its own interface.

If a figure on this suite is wrong, that is worth telling us about; data errors in upstream registries are common and a correction usually starts with someone noticing.

Principles we hold the products to

  • Show the source beside the value, or show nothing.
  • Prefer “unavailable” to a number nobody fetched.
  • State a limitation on the field it concerns, not in a footer.
  • Never present a prediction of success as if it were a finding — the products state in their own interfaces that they do not do this.
  • Keep the free surface genuinely usable rather than a locked demo.